1Parkin DM, Muir CS, Whelan SL, et al. Cancer incidence in five continents ( Vol. VI ). Lyon: international agency for research on cancer ( IARC Sientific publication NO 129 )[M]. Oxford : Oxford university press, 1992. 45.
4Mallinson CN, Rake MO, Cocking JB, et al. Chemotherapy in pancreatic cancer: results of a controlled,prospective, randomized, multicentre trial[J]. Br Med J, 1980, 281(6255):1589-1591.
5Palmer KR,Kerr M, Knowles,et al.Chemotherapy prolongs survival in inoperable pancreatic carcinoma[J].Br J Surg,1994,81(6):882-885.
6Haycox A, Lombard M, Neoptolemos J, et al. Review article: current treatment and optimal patient management in pancreatic cancer[J]. Aliment Pharmacol Ther,1998, 12(10):949-964.
7Knuth A,Bernhard H,Klein O,et al.Combination of fluorouracil, folinic acid, and interferon alpha-2a: an active regimen in advanced pancreatic carcinoma[J]. Semin Oncol, 1992, 19(Suppl 3): 211-214.
8Sauer-Heilborn A, Kath R, Schneider CP, et al. Severe non-haematological toxicity after treatment with gemcitabine[J]. J Cancer Res Clin Oncol, 1999, 125(11):637-640.
10Muchmore JH, Carter RD, Preslan JE, et al. Regional chemotherapy with hemofiltration: a rationale for a different treatment approach to advanced pancreatic cancer[J]. Hepatogastroenterology, 1996 ,43(8):346-355.
5George P. van der Schelling,Johannes Jeekel. Palliative Chemotherapy and Radiotherapy for Pancreatic Cancer: Is It Worthwhile?[J] 1999,World Journal of Surgery(9):950～953
6M. J. Humphreys,W. Greenhalf,J. P. Neoptolemos,P. Ghaneh. The potential for gene therapy in pancreatic cancer[J] 1999,International Journal of Pancreatology(1):5～21
7L. Staib,Karl Heinz Link,Hans Günther Beger. Immunotherapy in pancreatic cancer – current status and future[J] 1999,Langenbeck’s Archives of Surgery(4):396～404
8?. Andrén-Sandberg,D. Hoem,Pia Lena B?ckman. Other Risk Factors for Pancreatic Cancer: Hormonal Aspects[J] 1999,Annals of Oncology(4):131～135
9K. H. Link,A. Formentini,G. Leder,G. Fortnagel,N. Sartori,M. Schatz,H. G. Beger. Resection and radiochemotherapy of pancreatic cancer – the future?[J] 1998,Langenbecks Archiv für Chirurgie(2):134～144
10Mitsuhiro Mukaiya,Koichi Hirata,Takashi Satoh,Masami Kimura,Kazuhiro Yamashiro,Hideki Ura,Ikuo Oikawa,Ryuichi Denno. Lack of Survival Benefit of Extended Lymph Node Dissection for Ductal Adenocarcinoma of the Head of the Pancreas: Retrospective Multi-institutional Analysis in Japan[J] 1998,World Journal of Surgery(3):248～253
